Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.
01 1Synnat Pharma
02 1Axplora
03 1Polpharma
04 1LGM Pharma
05 1Jai Radhe Sales
06 1HRV Global Life Sciences
07 1Alchymars ICM SM
08 1Alkaloids Corporation
09 1Apotex Pharmachem
10 1Aurobindo Pharma Limited
11 1Aurore Life Sciences
12 1Brawn Laboratories Ltd
13 1Chr. Olesen Synthesis A.S
14 1Cipla
15 1Divis Laboratories
16 1ENAL DRUGS
17 1Fleming Laboratories
18 1Hetero Drugs
19 1Hoventa Pharma
20 1ITF CHEMICAL LTDA
21 2Ind Swift Laboratories Limited
22 2Ipca Laboratories
23 1JPN Pharma
24 1Jubilant Generics
25 1Jubilant Pharmova
26 1Macleods Pharmaceuticals Limited
27 1Orchid Pharma
28 1Permachem Asia, Ltd
29 1RR LIFESCIENCES
30 1Sun Pharmaceutical Industries Limited
31 1Synthimed Labs
32 1Teva API
33 1Teva Pharmaceutical Industries
34 1Trifarma
35 1UQUIFA
36 1Unipex
37 1Viatris
38 1Yangtze River Pharmaceutical Group
39 1Blank
01 1Brazil
02 1Canada
03 1China
04 1Denmark
05 1France
06 1Germany
07 26India
08 2Israel
09 1Italy
10 1Japan
11 1Poland
12 1Spain
13 2U.S.A
14 1Blank
01 14Active
02 3Inactive
03 24Blank
01 6Valid
02 1Withdrawn by Holder
03 34Blank
01 1221MF10189
02 1222MF10015
03 1222MF10030
04 1222MF10033
05 1223MF10141
06 1302MF10157
07 35Blank
01 1WC-0003
02 1WC-0015
03 1WC-0019
04 1WC-0023A3
05 1WC-0066
06 1WC-0079
07 1WC-0091
08 1WC-0092
09 1WC-0144
10 1WC-0159
11 1WC-0336
12 1WC-0491
13 29Blank
Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.
Date of Issue : 2022-03-18
Valid Till : 2025-05-28
Written Confirmation Number : WC-0019
Address of the Firm :
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-08-13
Pay. Date : 2012-12-11
DMF Number : 20384
Submission : 2007-03-26
Status : Active
Type : II
Certificate Number : R1-CEP 2013-126 - Rev 02
Issue Date : 2022-05-09
Type : Chemical
Substance Number : 2572
Status : Valid
Registration Number : 222MF10015
Registrant's Address : 19 Pellinska Str. 83-200 Starogard Gdanski POLAND
Initial Date of Registration : 2010-01-07
Latest Date of Registration : --
NDC Package Code : 12658-0604
Start Marketing Date : 1998-03-27
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Agerson Bio Co., Ltd.
Registration Date : 2022-01-21
Registration Number : 20100226-121-G-15-07(6)
Manufacturer Name : Pharmaceutical Works Polpharma S.A.
Manufacturer Address : 19. Pelplinska Str, 83-200 Starogard Gdanski, Poland
Available Reg Filing : ASMF, CA |
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16604
Submission : 2003-05-22
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21529
Submission : 2008-05-24
Status : Active
Type : II
Date of Issue : 2022-06-08
Valid Till : 2025-07-25
Written Confirmation Number : WC-0159
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24591
Submission : 2011-01-31
Status : Active
Type : II
NDC Package Code : 14998-0008
Start Marketing Date : 2010-09-07
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-09-21
Pay. Date : 2014-05-20
DMF Number : 25768
Submission : 2012-03-01
Status : Active
Type : II
We have 38 companies offering Risedronate Sodium API
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?